Bioterrorism-related inhalational anthrax in an elderly woman, Connecticut, 2001

Emerging Infectious Diseases

Volumn 9, Issue 6, 2003, Pages 681-688

  Griffith, Kevin S ^a,b   Mead, Paul ^a   Armstrong, Gregory L ^a   Painter, John ^a   Kelley, Katherine A ^b   Hoffmaster, Alex R ^a   Mayo, Donald ^b   Barden, Diane ^b   Ridzon, Renee ^a   Parashar, Umesh ^a   Teshale, Eyasu Habtu ^a   Williams, Jennifer ^a   Noviello, Stephanie ^a,c   Perz, Joseph F ^a   Mast, Eric E ^a   Swerdlow, David L ^a   Hadler, James L ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CDC   (United States)

^c NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIUM ISOLATE; BIOLOGICAL WARFARE; CASE REPORT; ENVIRONMENTAL FACTOR; EPIDEMIOLOGY; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LETTER; MACHINE; POSTAL MAIL; RURAL AREA; UNITED STATES;

EID: 0038581954     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0906.020728     Document Type: Article

References (21)

1. Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. MMWR Morb Mortal Wkly Rep 2001;50:941-8.
2. Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related inhalational anthrax - Connecticut, 2001. MMWR Morb Mortal Wkly Rep 2001;50:1049-51.
3. Barakat LA, Quentzel HL, Jernigan JA, Kirschke DL, Griffith K, Spear SM, et al. Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA 2002;287:863-8.
4. Jernigan J, Stephens D, Ashford D, Omenaca C, Topiel MS, Galbraith M, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001;7:933-44.
5. Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb Mortal Wkly Rep 2001;50:909-19.
6. Centers for Disease Control and Prevention. Epidemiologic notes and reports: anthrax - Connecticut. MMWR Morb Mortal Wkly Rep 1968;17:102.
7. Keim P, Price L, Klevytska A, Smith KL, Schupp JM, Okinaka R, et al. Multiple-locus variable-number tandem repeat analysis reveals genetic relationships with Bacillus anthracis. J Bacteriol 2000;182:2928-36.
8. Hoffmaster AR, Fitzgerald CC, Ribot E, Mayer LW, Popovic T. Molecular subtyping of Bacillus anthracis and the 2001 bioterrorism-associated anthrax outbreak, United States. Emerg Infect Dis 2002;8:1111-6.
9. Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related anthrax - Connecticut, 2001. MMWR Morb Mortal Wkly Rep 2001;50:1077-9.
10. Williams AA, Parashar UD, Stoica A, Ridzon R, Kirschke DL, Meyer RF, et al. Bioterrorism-related anthrax surveillance, Connecticut, September-December, 2001. Emerg Infect Dis 2002;8:1078-82.
11. Centers for Disease Control and Prevention. Comprehensive procedures for collecting environmental samples for culturing Bacillus anthracis (revised April 2002). Accessed March 2003. Available from URL: http://www.bt.cdc.gov/agent/anthrax/environmental-sampling-apr2002.asp
12. Teshale EH, Painter J, Burr GA, Mead P, Wright SV, Cseh LF, et al. Environmental sampling for spores of Bacillus anthracis. Emerg Infect Dis 2002;8:1083-7.
13. Centers for Disease Control and Prevention. Evaluation of Bacillus anthracis contamination inside the Brentwood mail processing and distribution center - District of Columbia, October 2001. MMWR Morb Mortal Wkly Rep 2001;50:1129-33.
14. Centers for Disease Control and Prevention, American Society of Microbiology, Association of Public Health Laboratories. Basic diagnostic testing protocols for level A laboratories for the presumptive identification of Bacillus anthracis. Accessed March 2003. Available from URL: http://www.bt.cdc.gov/agent/anthrax/LevelAProtocol/ban-la-cp-031802.pdf
15. Jernigan DB, Raghunathan PL, Bell BP, Brechner R, Bresnitz EA, Butler JC, et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 2002;8:1019-28.
16. Traeger MS, Wiersma ST, Rosenstein NE, Malecki JM, Shepard CW, Raghunathan PL, et al. First case of bioterrorism-related inhalational anthrax in the United States, Palm Beach, Florida, 2001. Emerg Infect Dis 2002;8:1029-34.
17. Hsu VP, Lukacs SL, Handzel T, Hayslett J, Harper S, Hales T, et al. Opening a Bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response. Emerg Infect Dis 2002;8:1039-44.
18. Ingelsby TV, O'Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002;287:2236-52.
19. Gleiser CA, Berdjis CC, Hartman HA, Gochenour WS. Pathology of experimental respiratory anthrax in Macaca mulatta. Br J Exp Pathol 1963;44:416-26.
20. Webb GF, Blaser MJ. Mailborne transmission of anthrax: modeling and implications. Proc Natl Acad Sci U S A 2002;99:7027-32.
21. Holtz TH, Ackelsburg JA, Kool J, Rosselli R, Marfin A, Matte T, et al. Isolated case of inhalational anthrax due to intentional contamination, New York City, 2001. Emerg Infect Dis 2003;9:689-96